About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Advertisement

Medindia » Health Press Releases A-Z

BioMarin Reports Encouraging Preliminary Data on BMN 110 for MPS IVA

Advertisement

Phase III Trial Expected to Start by Q4 2010 or Q1 2011

Contacts:

Investors	Media
Eugenia Shen	Susan Berg
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 506-6570	(415) 506-6594

Sponsored Post and Backlink Submission

Latest Press Release on Research News

Pre-clinical result of LP-005, a novel bi-functional complement antibody-fusion protein was unveiled by LongBio at WCN2024

BUENOS AIRES, Argentina , April 15, 2024 /PRNewswire/ -- LongBio Pharma (Suzhou) Co., Ltd. (referred to as "LongBio"), a leading biotech company dedicated to developing innovative...

ASICS Global Study Shows Link Between Regular Exercise in Teenage Years and Positive Mental Wellbeing in Adulthood

Global ASICS study of 26,000 people reaffirms the connection between movement and the mind and uncovers a direct link between teenage physical activity and adult mental wellbeing Eac...

Pacing Toward Progress: Dr. Daniel Corcos' Trailblazing Research Reveals Exercise's Potential to Slow Parkinson's Disease Progression

TORONTO , April 8, 2024 /PRNewswire/ -- Nearly one million people in the U.S. are currently living with Parkinson's disease (PD), a figure expected to surge to 1.2 million by 2030...

Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research

Strategic partnership expands Biognosys’ services to include Alamar’s NULISA assays as well as joint scientific research in biofluid-based proteomics Complementary value of Biognosys...

Premier Pediatric Research Center Adopts Complion's eISF Platform to Strengthen Pediatric Research Excellence

SAN ANTONIO , March 26, 2024 /PRNewswire/ -- Complion, LLC, a wholly owned subsidiary of RealTime Software Solutions, LLC and a leader in eRegulatory solutions, proudly announces ...

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use Ok, Got it. Close